Drug development is aiming to move from managing disease to correcting it through RNA and gene-editing therapies.

A research team led by geneticist Jeannie Lee at Harvard Medical School, cell biologist Jeanne Lawrence at UMass Chan Medical ...

Drug development is aiming to move from managing disease to correcting it through RNA and gene-editing therapies. But ...

But delivering these treatments safely and precisely to the right cells remains a major hurdle—especially in hard-to-target organs like the brain and kidneys. Now, researchers led by a University of ...

Of the 13 total, 2 awardees were chosen for the Company Formation award and 11 for the Technology Assessment awardCOLUMBIA, ...

Using 3D-printed pools and an Arduino, scientists recreated ancient hot springs and produced the crude protocells that may ...

Ribosomal RNA (rRNA), made from many copies of ribosomal DNA (rDNA), is the core component that powers ...

The CRISPR-Cas gene-editing system has long been the focus of research as a promising tool in genome editing. However, the emphasis has been on its underlying mechanisms and nucleases. In contrast, ...

Vaccines play a critical role in preventing infectious diseases, but their success often depends on adjuvants—substances that ...

A graduate student at Fred Hutch Cancer Center has produced a near real-time picture of how well the human immune system is ...

his is what computer science looks like at its best — advancing discovery while improving lives on a global scale.

The RNA world hypothesis posits that molecules made up of ribonucleic acids (RNA) are responsible for kickstarting evolution ...